|
|
3-Azabicyclo (3.3.0) Octane HCL
|
EY-0047PR
|
112626-50-3
|
≥98.0%,BR
|
|
￥0.0
|
|
|
|
20-Hydroxyarachidonic acid
|
EY-0056PR
|
79551-86-3
|
≥98.0%,BR
|
|
￥0.0
|
|
|
|
2-Acetylaminofluorene (2-AAF)
|
EY-0029PR
|
53-96-3
|
≥98.0%,BR
|
|
￥0.0
|
|
|
|
2,3,5,4-tetrahydroxyl diphenylethylene-2-o-glucoside
|
EY-0078PR
|
82373-94-2
|
≥98.0%,BR
|
|
￥0.0
|
|
|
|
Ginsenoside Rg3
|
EY-0042PR
|
14197-60-5
|
≥98.0%,BR
|
|
￥0.0
|
|
|
|
(s)-10-hydroxycamptothecin
|
EY-0075PR
|
19685-09-7
|
≥98.0%,BR
|
|
￥0.0
|
|
|
|
20(R)Ginsenoside?Rh1
|
EY-0046PR
|
80952-71-2
|
≥98.0%,BR
|
|
￥0.0
|
|
|
|
20(R)Ginsenoside Rg2
|
EY-0041PR
|
80952-72-3
|
≥98.0%,BR
|
|
￥0.0
|
|
|
|
(-)-Syringaresnol-4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyran
|
EY-0040PR
|
136997-64-3
|
≥98.0%,BR
|
|
￥0.0
|
|
|
|
3,5-dibromo-benzoic acid，3,5-dibromobenzoic acid
|
EY-0036PR
|
69251-96-3
|
≥98.0%,BR
|
|
￥0.0
|
|
|
|
(+)-Catechin hydrate
|
EY-0045PR
|
225937-10-0
|
≥98.0%,BR
|
|
￥0.0
|
|
